2008
Prenatal Caffeine Assessment: Fetal and Maternal Biomarkers or Self-Reported Intake?
Grosso LM, Triche E, Benowitz NL, Bracken MB. Prenatal Caffeine Assessment: Fetal and Maternal Biomarkers or Self-Reported Intake? Annals Of Epidemiology 2008, 18: 172-178. PMID: 18083538, PMCID: PMC2275917, DOI: 10.1016/j.annepidem.2007.11.005.Peer-Reviewed Original ResearchConceptsMaternal urineCaffeine exposureUmbilical cord blood samplesCord blood biomarkersCord blood concentrationsInfants of smokersMaternal self reportsMaternal caffeine intakeCord blood samplesSelf-reported intakeUmbilical cord bloodMaternal biomarkersPregnant womenBlood biomarkersCord bloodObstetric practiceBlood concentrationsCaffeine intakeParaxanthine levelsBlood samplesPregnancySmokersCaffeine metabolismIntakeBiomarkersGenetic influences on smoking cessation and relapse in pregnant women
Triche E, Hossain N, Paidas M. Genetic influences on smoking cessation and relapse in pregnant women. Journal Of Obstetrics And Gynaecology 2008, 28: 155-160. PMID: 18393009, DOI: 10.1080/01443610801912725.Peer-Reviewed Original ResearchConceptsLow birth weight infantsBirth weight infantsPregnant womenWeight infantsSmoking behaviorNegative long-term health consequencesLong-term health consequencesPre-term deliverySignificant public health concernFetal growth restrictionLow birth weightPublic health concernAuditory processing deficitsMaternal smokingObstetrical complicationsPlacental problemsCigarette smokingSmoking cessationBirth weightGrowth restrictionSpontaneous abortionPlacental functionLong-term consequencesRespiratory conditionsGenetic influences
2006
Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction
Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR, Bracken MB. Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction. American Journal Of Epidemiology 2006, 163: 1035-1041. PMID: 16641310, DOI: 10.1093/aje/kwj125.Peer-Reviewed Original ResearchConceptsIntrauterine growth restrictionRisk of IUGRUmbilical cord bloodGrowth restrictionCord bloodCaffeine consumptionRatio of paraxanthineCytochrome PSelf-reported caffeine consumptionPreterm deliveryFetal exposureHighest quartileAdjusted analysisPregnant womenFetal growthObstetric practiceCYP1A2 activityParaxanthine levelsReproductive outcomesAdjusted modelAssociation of caffeineCaffeine metabolitesStandard deviation changeConflicting resultsQuartileThe Epidemiology of Asthma During Pregnancy: Prevalence, Diagnosis, and Symptoms
Kwon HL, Triche EW, Belanger K, Bracken MB. The Epidemiology of Asthma During Pregnancy: Prevalence, Diagnosis, and Symptoms. Immunology And Allergy Clinics Of North America 2006, 26: 29-62. PMID: 16443142, DOI: 10.1016/j.iac.2005.11.002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPregnant womenLarge prospective cohort studyEpidemiology of asthmaProspective cohort studySelf-reported asthmaPopulation-level improvementsAsthma controlCohort studyAsthma diagnosisAsthma attacksCommon conditionPrevalence ratesClinical involvementAsthmaNational dataPregnancyPrevalenceDiagnosisWomenUnited StatesPopulation characteristicsRepresentative dataPrevious yearFurther researchFurther characterization
2003
Asthma Symptoms, Severity, and Drug Therapy: A Prospective Study of Effects on 2205 Pregnancies
Bracken M, Triche E, Belanger K, Saftlas A, Beckett W, Leaderer B. Asthma Symptoms, Severity, and Drug Therapy: A Prospective Study of Effects on 2205 Pregnancies. Obstetrics And Gynecology 2003, 102: 739. DOI: 10.1097/00006250-200310000-00016.Peer-Reviewed Original ResearchAsthma symptomsOral steroidsAsthma diagnosisPreterm deliveryPregnant womenHistory of asthmaIntrauterine growth restrictionIUGR infantsAsthma guidelinesAsthma historyController medicationsModerate asthmaPregnant patientsAsthma therapySymptomatic patientsAsthma severityFetal effectsSymptomatic womenProspective studyDrug therapyGrowth restrictionΒ2 agonistsAsthmaSymptomsMedicationsAsthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies.
Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstetrics And Gynecology 2003, 102: 739-52. PMID: 14551004, DOI: 10.1016/s0029-7844(03)00621-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Asthmatic AgentsAnti-Inflammatory AgentsAsthmaBirth WeightCase-Control StudiesConnecticutFemaleFetal Growth RetardationFetal Membranes, Premature RuptureHumansInfant, Low Birth WeightInfant, NewbornMassachusettsPregnancyPregnancy ComplicationsPregnancy OutcomeProspective StudiesRisk FactorsSeverity of Illness IndexSteroidsTheophyllineConceptsAsthma symptomsOral steroidsAsthma diagnosisPreterm deliveryPregnant womenHistory of asthmaIntrauterine growth restrictionIUGR infantsAsthma guidelinesAsthma historyController medicationsModerate asthmaAsthma therapyPregnant patientsSymptomatic patientsAsthma severityFetal effectsSymptomatic womenProspective studyDrug therapyGrowth restrictionAsthmaSymptomsMedicationsDiagnosis
2002
Heterogeneity in Assessing Self-Reports of Caffeine Exposure
Bracken MB, Triche E, Grosso L, Hellenbrand K, Belanger K, Leaderer BP. Heterogeneity in Assessing Self-Reports of Caffeine Exposure. Epidemiology 2002, 13: 165-171. PMID: 11880757, DOI: 10.1097/00001648-200203000-00011.Peer-Reviewed Original Research